These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20739468)

  • 21. AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1).
    Gargiulo A; Bonetti C; Montefusco S; Neglia S; Di Vicino U; Marrocco E; Corte MD; Domenici L; Auricchio A; Surace EM
    Mol Ther; 2009 Aug; 17(8):1347-54. PubMed ID: 19436266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iris phenotypes and pigment dispersion caused by genes influencing pigmentation.
    Anderson MG; Hawes NL; Trantow CM; Chang B; John SW
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):565-78. PubMed ID: 18715234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrp1 and oculocutaneous albinism type 3.
    Sarangarajan R; Boissy RE
    Pigment Cell Res; 2001 Dec; 14(6):437-44. PubMed ID: 11775055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.
    Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
    Mol Vis; 2010 Aug; 16():1514-24. PubMed ID: 20806075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iris hyperpigmentation in a Chinese family with ocular albinism and the GPR143 mutation.
    Xiao X; Zhang Q
    Am J Med Genet A; 2009 Aug; 149A(8):1786-8. PubMed ID: 19610097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albinism: an update.
    Orlow SJ
    Semin Cutan Med Surg; 1997 Mar; 16(1):24-9. PubMed ID: 9125762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the iris thickness changes for the Chinese families with GPR143 gene mutations.
    Jiang J; Yang L; Li H; Huang L; Li N
    Exp Eye Res; 2019 Dec; 189():107819. PubMed ID: 31574285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of oculocutaneous albinism with molecular analysis.
    Summers CG; Oetting WS; King RA
    Am J Ophthalmol; 1996 Jun; 121(6):724-6. PubMed ID: 8644824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural analysis of the pigment dispersion syndrome in DBA/2J mice.
    Schraermeyer M; Schnichels S; Julien S; Heiduschka P; Bartz-Schmidt KU; Schraermeyer U
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1493-504. PubMed ID: 19641932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
    Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the
    Monfermé S; Lasseaux E; Duncombe-Poulet C; Hamel C; Defoort-Dhellemmes S; Drumare I; Zanlonghi X; Dollfus H; Perdomo Y; Bonneau D; Korobelnik JF; Plaisant C; Michaud V; Pennamen P; Rooryck-Thambo C; Morice-Picard F; Paya C; Arveiler B
    Br J Ophthalmol; 2019 Sep; 103(9):1239-1247. PubMed ID: 30472657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice.
    Scholz M; Buder T; Seeber S; Adamek E; Becker CM; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):613-21. PubMed ID: 18235006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
    Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
    Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma.
    Anderson MG; Libby RT; Mao M; Cosma IM; Wilson LA; Smith RS; John SW
    BMC Biol; 2006 Jul; 4():20. PubMed ID: 16827931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase.
    Libby RT; Smith RS; Savinova OV; Zabaleta A; Martin JE; Gonzalez FJ; John SW
    Science; 2003 Mar; 299(5612):1578-81. PubMed ID: 12624268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of pigment dispersion syndrome and pigmentary glaucoma.
    Lascaratos G; Shah A; Garway-Heath DF
    Surv Ophthalmol; 2013; 58(2):164-75. PubMed ID: 23218808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.